Ikarian Capital »

Connect Biopharma Hldgs shares owned by Ikarian Capital

Quarter-by-quarter ownership of Connect Biopharma Hldgs (CNTB) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Connect Biopharma Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Connect Biopharma Hldgs held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Connect Biopharma Hldgs by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $14M 4.9M 2.82

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Connect Biopharma Hldgs

Ikarian Capital
Boothbay Fund Management
BML Capital Management
Knott David M Jr
Richmond Brothers
Renaissance Technologies
Marshall Wace
Jane Street
OMERS Administration Corporation
Susquehanna International
Koa Wealth Management
Persistent Asset Partners
Geode Capital Management
Hrt Financial
Point72 Asset Management

View all funds holding Connect Biopharma Hldgs